The prognosis of lupus nephritis in African-Americans: a retrospective analysis (Q33491801)

27 July 2017

The prognosis of lupus nephritis in African-Americans: a retrospective analysis (English)

1 reference

27 July 2017

1 reference

Bakir AA

1

1 reference

27 July 2017

Levy PS

series ordinal

2

1 reference

27 July 2017

Dunea G

series ordinal

3

1 reference

27 July 2017

language of work or name

1 reference

1 August 1994

1 reference

American Journal of Kidney Diseases

27 July 2017

1 reference

27 July 2017

24

1 reference

27 July 2017

159-171

1 reference

27 July 2017

2

1 reference

The 1982 revised criteria for the classification of systemic lupus erythematosus

27 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

The prognosis of segmental glomerulonephritis in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Clinical outcome of three discrete histologic patterns of injury in severe lupus glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Lupus nephritis: clinicopathological study of 162 cases in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Lupus nephritis: lessons from the path lab.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Prognostic factors in diffuse proliferative lupus glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Lupus nephritis at the University Hospital of the West Indies, Kingston, Jamaica: a 10-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Clinical features of systemic lupus erythematosus: differences related to race and age of onset

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

DNA analysis of HLA-DR and DQ genes in American blacks with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Morbidity of systemic lupus erythematosus: role of race and socioeconomic status.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

The relationship of socioeconomic status to subsequent health status in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Nephrotic syndrome, hematuria, and hypocomplementemia in a case of mesangial lupus nephritis evolving later to a membranous lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Use of the Megathrombocyte as an Index of Megakaryocyte Number

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Platelet antibody in autoimmune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Hematologic aspects of systemic lupus erythematosus. Current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980177-6

7 January 2021

10.1016/S0272-6386(12)80177-6

Identifiers

DOI

1 reference

27 July 2017

1 reference